AEOVIAN PHARMACEUTICALS
Current Employees Featured
Official Site Inspections
http://www.aeovian.com
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Aeovian Pharmaceuticals"
Aeovian Pharmaceuticals Inc.
Mar 28, 2024 Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway. top of page. Home. About. Our Team. Our Board. Our Advisors. Contact. …See details»
Aeovian Pharmaceuticals - Crunchbase Company …
Aeovian Pharmaceuticals is a San Francisco Bay Area-based biopharmaceutical company aiming to discover, develop, and commercialize innovative therapeutics for the treatment of rare and age-related diseases. The company is …See details»
Aeovian Pharmaceuticals - Crunchbase Company …
Aeovian Pharmaceuticals is located in Walnut Creek, California, United States. Who invested in Aeovian Pharmaceuticals? Aeovian Pharmaceuticals is funded by FJ Labs. When was the last funding round for Aeovian Pharmaceuticals? …See details»
Aeovian Pharmaceuticals - Overview, News & Similar companies
Mar 28, 2024 View Aeovian Pharmaceuticals (www.aeovian.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as …See details»
Aeovian Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Nov 1, 2024 About Aeovian Aeovian Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted and highly selective small molecules to restore cellular …See details»
Aeovian Pharmaceuticals - LinkedIn
Aeovian Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted and highly selective small molecules to restore cellular metabolic quality control, thereby …See details»
Aeovian Pharmaceuticals - Craft
Aeovian Pharmaceuticals is a biopharmaceutical company specializing in therapeutics for the treatment of rare and age-related diseases. It develops selective modulators of the mTORC1 …See details»
Aeovian Pharmaceuticals - Funding, Financials, Valuation & Investors
Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases. Search Crunchbase. ... How much funding has …See details»
Aeovian Pharmaceuticals | CipherBio
Explore Aeovian Pharmaceuticals's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
JUSTIN GOVER - Aeovian NEW
From 2018-2021, Mr. Gover served on the Board of Directors of the Biotechnology Innovation Organization (BIO). Mr. Gover served as CEO and a Board Director of GW since the …See details»
Allison J. Hulme | Aeovian NEW
Dr. Hulme joined Aeovian in January 2020 as CEO, President and Board Member, bringing with her 30 years of experience in drug development and commercialization. Prior to this, she was the Chief Operating Officer, Head of …See details»
Aeovian Pharmaceuticals - Contacts, Employees, Board Members, …
Aeovian Pharmaceuticals is a biopharmaceutical company that focuses on developing innovative therapeutic treatments.See details»
AEOVIAN PHARMACEUTICALS DOSES FIRST PARTICIPANTS IN …
Mar 28, 2024 Aeovian Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel and highly selective therapeutics that potently inhibit the mTORC1 pathway, today …See details»
Davis Ryman - Aeovian NEW
Dr Ryman is a neurologist and geneticist by training, and joined Aeovian in November 2022 as Chief Medical Officer. Prior to joining, he was most recently Chief Medical Officer of Levo …See details»
Aeovian Pharmaceuticals - Contacts, Employees, Board Members, …
Aeovian Pharmaceuticals has 4 current employee profiles, including CEO Allison Hulme. Aeovian Pharmaceuticals has 3 board members and advisors, including William Greene . ContactsSee details»
AEOVIAN PHARMACEUTICALS DOSES FIRST PARTICIPANTS IN …
Mar 28, 2024 Aeovian Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel and highly selective therapeutics that potently inhibit the mTORC1 pathway, today …See details»
John Kincaid - Aeovian NEW
Mr. Kincaid joined Aeovian in March 2020 as Chief Scientific Officer. He brings 25 years of drug discovery experience where his teams have led several compounds into clinical trials. He is an …See details»
AEOVIAN PHARMACEUTICALS DOSES FIRST PARTICIPANTS IN …
Mar 28, 2024 Aeovian Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted and highly selective small molecules to restore cellular metabolic quality …See details»
David Lowe - Aeovian NEW
Dr. Lowe was member of the founding team of Aeovian. He is president and CEO of NeuroAssets Sarl, a Swiss-based neuroscience-focused consulting firm providing advisory services to …See details»
William Greene | Aeovian NEW
Dr. William Greene’s leadership positions have included founder, biotechnology executive, investor, and clinician. As CEO, he built Iconic Therapeutics through discovery, clinical …See details»